GATA6 and neoplasm: Although initially it was considered that GATA6 could have an oncogenic role in PDAC because its amplification and over-expression contributed to cell proliferation and cell cycle progression [19,20], more recently, a tumor-suppressive role in PDAC mouse models has been proposed [21].